Is it time to stage prostate cancer using molecular imaging?

Authors : Özer GÜZEL, Fazlı POLAT, Ali ATAN

Pages : 109-115

Doi:10.33719/yud.2022;17-2-1035767

View : 15 | Download : 5

Publication Date : 2022-06-30

Article Type : Research Paper

Abstract :Prostate cancer is one of the most common cancers in men. After the diagnosis is made, staging should be undertaken with imaging methods in order to plan the treatment and predict the prognosis. Parallel to technological developments in recent years, new imaging methods have entered into clinical use. Among these methods, prostate-specific membrane antigen insert ignore into journalissuearticles values(PSMA); positron emission tomography insert ignore into journalissuearticles values(PET); imaging has come to the fore since it provides anatomical and functional imaging and has many advantages in tumor insert ignore into journalissuearticles values(T);, nodal insert ignore into journalissuearticles values(N); and metastatic insert ignore into journalissuearticles values(M); staging. This review discusses the current status of the PSMA-PET method in prostate cancer staging.
Keywords : Prostat kanseri, evreleme, pozitron emisyon tomografi